The forgotten right ventricle in cardio-oncology
J Nucl Cardiol
.
2020 Dec;27(6):2164-2166.
doi: 10.1007/s12350-019-01602-5.
Epub 2019 Feb 15.
Authors
Eiman Jahangir
1
2
3
,
Matthew E Harinstein
4
,
Venkatesh L Murthy
5
,
Javid Moslehi
6
7
8
Affiliations
1
Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
2
Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
3
Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
4
Division of Cardiology, Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
5
Division of Cardiovascular Medicine, Department of Internal Medicine and Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, USA.
6
Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. javid.moslehi@vanderbilt.edu.
7
Division of Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. javid.moslehi@vanderbilt.edu.
8
Cardio-Oncology Program, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. javid.moslehi@vanderbilt.edu.
PMID:
30771160
PMCID:
PMC6697233
DOI:
10.1007/s12350-019-01602-5
No abstract available
Publication types
Editorial
Comment
MeSH terms
Cardiotoxicity
Fluorodeoxyglucose F18*
Heart Ventricles / diagnostic imaging
Humans
Myocardium
Neoplasms*
Substances
Fluorodeoxyglucose F18
Grants and funding
R01 HL141466/HL/NHLBI NIH HHS/United States
R01 HL155990/HL/NHLBI NIH HHS/United States
R56 HL141466/HL/NHLBI NIH HHS/United States